Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
- PublisherINT INST ANTICANCER RESEARCH
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year1987
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has In Vivo been publishing? 
The In Vivo has been publishing since 1987 till date.
How frequently is the In Vivo published? 
In Vivo is published Bi-monthly.
Who is the publisher of In Vivo? 
The publisher of In Vivo is INT INST ANTICANCER RESEARCH.
How can I view the journal metrics of In Vivo on editage? 
For the In Vivo metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of In Vivo? 
The eISSN number is 1791-7549 and pISSN number is 0258-851X for In Vivo.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Cancer, Overall survival, Amino acid, Lung cancer, Sarcopenia, Lymph node, Neurofibromatosis, Chemoradiotherapy, Genotype, Hepatocellular carcinoma, Cerebral cortex, Breast cancer, Irradiation, Partial response, Thrombotic microangiopathy, Lung, Surgery, Reactive oxygen species, Adjuvant, Osteoid osteoma.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.